Pharmaceutical News

RSS

MDI Biological Laboratory researchers receive patent for novel heart disease drug

The U.S. Patent and Trademark Office has announced that it will grant a patent to MDI Biological Laboratory scientists Voot P. Yin, Ph.D., and Kevin Strange, Ph.D., and their collaborator Michael Zasloff, M.D., Ph.D., for use of the small molecule MSI-1436 to stimulate the repair and regeneration of heart tissue damaged by injuries such as a heart attack.

23 Aug 2016

TMDU researchers inject gelatin-based gel carrying protein/peptide drugs to trigger bone augmentation

The part of the jawbone containing tooth sockets is known as alveolar bone, and its loss over time or following dental disease may ultimately result in tooth loss.

23 Aug 2016

Cloned Zika virus could be used for development of attenuated vaccine

Stopping the explosive spread of Zika virus - which can lead to birth defects in babies born to infected mothers - depends on genetic insights gleaned through new tools and models.

23 Aug 2016

New drug target could help prevent opioid tolerance and addiction

Researchers have identified a brain mechanism that could be a drug target to help prevent tolerance and addiction to opioid pain medication, such as morphine, according to a study by Georgia State University and Emory University.

23 Aug 2016

New study aims to find how genes that influence brain function cause risk for drug addiction

A new study aims to better understand what makes some individuals particularly vulnerable to developing drug addiction. A team of researchers from across the country will look at how genes that influence brain function cause risk for addictions.

23 Aug 2016

$Study looks at ways to reduce prescription drugs linked to fracture risk among older adults$

Study looks at ways to reduce prescription drugs linked to fracture risk among older adults

Fragility fractures -- those that occur at standing height -- are a significant source of sickness and death among the elderly population in the United States. They are also associated with annual direct costs of over $16 billion.

23 Aug 2016

QUT molecular microbiologist developing new therapies to beat bacterial superbugs

QUT molecular microbiologist Makrina Totsika is at the forefront of research to develop new therapies to beat multi-drug resistant bacteria.

22 Aug 2016

New study examines effectiveness of pictogram labels on medication-related road traffic crash risk

A new study questions the effectiveness of using pictogram message on the labels of anxiety and sleep medications that interfere with driving - an approach this is currently implemented across France.

22 Aug 2016

NYIT researcher aims to study link between wound healing problems and methamphetamine use

A chance observation in a Southern California fast food restaurant led Luis Martinez, Ph.D., to wonder about the connections behind wound healing problems and methamphetamine use.

19 Aug 2016

Genekam develops first therapeutic molecule candidate for Zika viruses

GenekamBiotechnology AG, which developed the first test for Zika virus detection in January 2016, has developed as one of first company in the world the therapeutic molecule candidate for Zika viruses, which is likely to be the first potential candidate for Zika-virus therapy.

19 Aug 2016

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Nivolumab has been approved since April 2016 as a checkpoint inhibitor for the treatment of adults with locally advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC) who have already undergone chemotherapy.

19 Aug 2016

Added benefit of combination drug for HIV-infected patients not proven

The drug combination emtricitabine/tenofovir alafenamide is approved in combination with other antiviral agents for the treatment of adults and adolescents infected with human immunodeficiency virus type 1 (HIV-1).

19 Aug 2016

Added benefit of lung cancer drug not proven, says IQWiG

Afatinib (trade name: Giotrif) has been approved since April 2016 for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) of squamous histology who have already received chemotherapy.

19 Aug 2016

Added benefit not proven for orphan drug in treatment of adults with stomach cancer

Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.

19 Aug 2016

Added benefit still not proven for epilepsy drug

Brivaracetam (trade name: Briviact) has been approved since January 2016 as add-on therapy for adults and adolescents from 16 years of age with epileptic seizures.

19 Aug 2016

Many parents support HPV vaccine school-entry requirements with opt-out provisions

Requiring students to get vaccinated against the human papillomavirus, or HPV, to enter school could prevent many cancers linked to the virus, but University of North Carolina at Chapel Hill researchers found that many parents only support such requirements with opt-out provisions that could make the laws less effective.

19 Aug 2016

Pharmaceutical News

MDI Biological Laboratory researchers receive patent for novel heart disease drug

TMDU researchers inject gelatin-based gel carrying protein/peptide drugs to trigger bone augmentation

Cloned Zika virus could be used for development of attenuated vaccine

New drug target could help prevent opioid tolerance and addiction

New study aims to find how genes that influence brain function cause risk for drug addiction

Study looks at ways to reduce prescription drugs linked to fracture risk among older adults

QUT molecular microbiologist developing new therapies to beat bacterial superbugs

New study examines effectiveness of pictogram labels on medication-related road traffic crash risk

NYIT researcher aims to study link between wound healing problems and methamphetamine use

Genekam develops first therapeutic molecule candidate for Zika viruses

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Added benefit of combination drug for HIV-infected patients not proven

Added benefit of lung cancer drug not proven, says IQWiG

Added benefit not proven for orphan drug in treatment of adults with stomach cancer

Added benefit still not proven for epilepsy drug

Many parents support HPV vaccine school-entry requirements with opt-out provisions

Men experience greater pain relief than women after smoking marijuana, study finds

TSRI scientists find evidence supporting new therapeutic strategy against cocaine addiction

Popular pain and fever reliever does not worsen asthma in children, study shows

Diabetes medication offers protection against arterial stiffness in overweight female mice

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News